Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming investor conference:
BTIG Biotechnology Conference, New-York
Event Date: August 8-9, 2022
| Press Release in English | 139.85 KB |
| Communiqué de presse en français | 144.02 KB |